Real-World Effectiveness of Intravitreal Dexamethasone Implants - Comparison between Eyes Eligible and Ineligible for Clinical Trials and Their Associated Outcomes.
暂无分享,去创建一个
Wei-Chi Wu | Chi-Chun Lai | Y. Hwang | Kuan-Jen Chen | Sunir J. Garg | Kai-Cheng Chang | S. Shao | Tzu-Yi Lin | Edward Chia-Cheng Lai | Eugene Yu-Chuan Kang
[1] Chi-Chun Lai,et al. Comparison of Sodium-Glucose Cotransporter 2 Inhibitors vs Glucagonlike Peptide-1 Receptor Agonists and Incidence of Dry Eye Disease in Patients With Type 2 Diabetes in Taiwan , 2022, JAMA network open.
[2] S. Shao,et al. Validation of Diagnostic Codes to Identify Carbon Monoxide Poisoning in Taiwan’s Claims Data , 2022, Frontiers in Pharmacology.
[3] Swu-Jane Lin,et al. Positive Predictive Value of ICD-10 Codes for Cerebral Venous Sinus Thrombosis in Taiwan’s National Health Insurance Claims Database , 2022, Clinical epidemiology.
[4] Chi-Chun Lai,et al. Association between Sodium Glucose Co-transporter 2 Inhibitors and Incident Glaucoma in Patients with Type 2 Diabetes: A Multi-institutional Cohort Study in Taiwan. , 2022, Diabetes & metabolism.
[5] Y. Huang,et al. Discharge status validation of the Chang Gung Research database in Taiwan , 2021, Biomedical journal.
[6] J. Rodrigues,et al. Dexamethasone intravitreal implant (Ozurdex) in diabetic macular edema: real-world data versus clinical trials outcomes. , 2021, International journal of ophthalmology.
[7] S. Garg,et al. Intravitreal Dexamethasone Implants for Refractory Macular Edema in Eyes with Noninfectious Uveitis , 2021, Journal of clinical medicine.
[8] Chi-Chun Lai,et al. Risk of diabetic macular oedema with sodium‐glucose cotransporter‐2 inhibitors in type 2 diabetes patients: A multi‐institutional cohort study in Taiwan , 2021, Diabetes, obesity & metabolism.
[9] C. Lange,et al. Real-life medium term follow-up data for intravitreal dexamethasone implant in retinal vein occlusion , 2021, Scientific Reports.
[10] R. Gallemore,et al. Initial Ten Years of Experience with the Intravitreal Dexamethasone Implant: A Retrospective Chart Review , 2020, Clinical ophthalmology.
[11] Mário Ornelas,et al. Macular edema secondary to retinal vein occlusion in a real-life setting: a multicenter, nationwide, 3-year follow-up study , 2020, Graefe's Archive for Clinical and Experimental Ophthalmology.
[12] Shu Yang,et al. Improving trial generalizability using observational studies , 2020, Biometrics.
[13] A. Pottegård,et al. Differences Between Randomized Clinical Trial Participants and Real-World Empagliflozin Users and the Changes in Their Glycated Hemoglobin Levels. , 2020, JAMA network open.
[14] E. Lai,et al. Sodium glucose co-transporter 2 inhibitors and cardiovascular event protections: how applicable are clinical trials and observational studies to real-world patients? , 2019, BMJ Open Diabetes Research & Care.
[15] P. Lu,et al. Association of glaucoma with risk of retinal vein occlusion: A meta‐analysis , 2019, Acta ophthalmologica.
[16] S. Sivaprasad,et al. A Collaborative Retrospective Study on the Efficacy and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema: The European DME Registry Study. , 2019, Ophthalmology.
[17] E. Lai,et al. Comparative risk evaluation for cardiovascular events associated with dapagliflozin vs. empagliflozin in real-world type 2 diabetes patients: a multi-institutional cohort study , 2019, Cardiovascular Diabetology.
[18] D. Webb,et al. Pharmacoepidemiology: Using randomised control trials and observational studies in clinical decision‐making , 2019, British journal of clinical pharmacology.
[19] P. Campochiaro,et al. Loss of Peak Vision in Retinal Vein Occlusion Patients Treated for Macular Edema. , 2019, American journal of ophthalmology.
[20] Y. Kao Yang,et al. The Chang Gung Research Database—A multi‐institutional electronic medical records database for real‐world epidemiological studies in Taiwan , 2019, Pharmacoepidemiology and drug safety.
[21] J. Garcia-Arumi,et al. Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world , 2019, PloS one.
[22] C. Kim,et al. Intraocular pressure change after injection of intravitreal dexamethasone (Ozurdex) implant in Korean patients , 2018, British Journal of Ophthalmology.
[23] M. Maia,et al. Effectiveness and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema: A Real-World Experience , 2018, Ophthalmologica.
[24] U. Schmidt-Erfurth,et al. Correlation of Central Retinal Thickness and Visual Acuity in Diabetic Macular Edema. , 2018, JAMA ophthalmology.
[25] A. Mansour,et al. Long-term visual outcome and its predictors in macular oedema secondary to retinal vein occlusion treated with dexamethasone implant , 2018, British Journal of Ophthalmology.
[26] A. Capone,et al. Real-World Assessment of Dexamethasone Intravitreal Implant in DME: Findings of the Prospective, Multicenter REINFORCE Study. , 2018, Ophthalmic surgery, lasers & imaging retina.
[27] M. Larsen,et al. Diabetic macular oedema treated with intravitreal anti‐vascular endothelial growth factor – 2–4 years follow‐up of visual acuity and retinal thickness in 566 patients following Danish national guidelines , 2018, Acta ophthalmologica.
[28] Mei-Ching Lee,et al. Association of Varicose Veins With Incident Venous Thromboembolism and Peripheral Artery Disease , 2018, JAMA.
[29] J. Chhablani,et al. Early Response to Intravitreal Dexamethasone Implant Therapy in Diabetic Macular Edema May Predict Visual Outcome. , 2017, American journal of ophthalmology.
[30] Wen-Cheng Chen,et al. Chang Gung Research Database: A multi-institutional database consisting of original medical records , 2017, Biomedical journal.
[31] S. Sivaprasad,et al. Identification of time point to best define ‘sub-optimal response’ following intravitreal ranibizumab therapy for diabetic macular edema based on real-life data , 2017, Eye.
[32] L. Joskowicz,et al. Comparison of Snellen and Early Treatment Diabetic Retinopathy Study charts using a computer simulation. , 2016, International journal of ophthalmology.
[33] S. Whitcup,et al. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. , 2014, Ophthalmology.
[34] Dan Lindfield,et al. Dexamethasone implants in retinal vein occlusion: 12-month clinical effectiveness using repeat injections as-needed , 2013, British Journal of Ophthalmology.
[35] Pedro Romero-Aroca,et al. Managing diabetic macular edema: The leading cause of diabetes blindness. , 2011, World journal of diabetes.
[36] C. Lowder,et al. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. , 2011, Archives of ophthalmology.
[37] M. Blumenkranz,et al. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. , 2010, Ophthalmology.
[38] Peter K Kaiser,et al. Prospective evaluation of visual acuity assessment: a comparison of snellen versus ETDRS charts in clinical practice (An AOS Thesis). , 2009, Transactions of the American Ophthalmological Society.
[39] Ingrid U Scott,et al. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. , 2009, Archives of ophthalmology.
[40] M. Gillies,et al. Intravitreal Triamcinolone Acetonide Inhibits Breakdown of the Blood-Retinal Barrier Through Differential Regulation of VEGF-A and Its Receptors in Early Diabetic Rat Retinas , 2008, Diabetes.
[41] Michael Bach,et al. Visual acuities "hand motion" and "counting fingers" can be quantified with the freiburg visual acuity test. , 2006, Investigative ophthalmology & visual science.
[42] Hiroshi Tamura,et al. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina. , 2005, Investigative ophthalmology & visual science.
[43] Paris G Tranos,et al. Macular edema. , 2004, Survey of ophthalmology.